AbbVie has officially published its final analysis of the confirmatory Phase 3 MIRASOL trial, which evaluated the efficacy and safety of ELAHERE® (mirvetuximab soravtansine-gynx)...
Eli Lily has officially announced, in collaboration with Incyte, new results that found the company's baricitinib drug was able to achieve positive results when...
Blueprint Medicines Corporation has officially published its data presentations that give an insight into the company's ongoing efforts to advance the treatment for mast...
Amberen®, a leading brand in symptom relief innovation supporting all phases of menopause, has officially announced the launch of Amberen ENERGY MOOD SLEEP, which...
Fullpower Technologies, in collaboration with Stanford Sleep Medicine and UCSF Department of Psychiatry and Behavioral Sciences, has officially presented two new studies at the...